CA2291260A1 - 207 proteines secretees par l'etre humain - Google Patents

207 proteines secretees par l'etre humain Download PDF

Info

Publication number
CA2291260A1
CA2291260A1 CA002291260A CA2291260A CA2291260A1 CA 2291260 A1 CA2291260 A1 CA 2291260A1 CA 002291260 A CA002291260 A CA 002291260A CA 2291260 A CA2291260 A CA 2291260A CA 2291260 A1 CA2291260 A1 CA 2291260A1
Authority
CA
Canada
Prior art keywords
gene
tissues
polypeptides
seq
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002291260A
Other languages
English (en)
Inventor
Paul Young
John M. Greene
Ann M. Ferrie
Steven M. Ruben
Craig A. Rosen
Jing-Shan Hu
Henrik S. Olsen
Reinhard Ebner
Laurie A. Brewer
Paul A. Moore
Yanggu Shi
Charles Florence
Kimberly Florence
David W. Lafleur
Jian Ni
Ping Fan
Ying-Fei Wei
Carrie L. Fischer
Daniel R. Soppet
Yi Li
Zhizhen Zeng
Hla Kyaw
Guo-Liang Yu
Ping Feng
Patrick J. Dillon
Gregory A. Endress
Kenneth C. Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2291260A1 publication Critical patent/CA2291260A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002291260A 1997-06-06 1998-06-04 207 proteines secretees par l'etre humain Abandoned CA2291260A1 (fr)

Applications Claiming Priority (147)

Application Number Priority Date Filing Date Title
US4887797P 1997-06-06 1997-06-06
US4888397P 1997-06-06 1997-06-06
US4890097P 1997-06-06 1997-06-06
US4887697P 1997-06-06 1997-06-06
US4897097P 1997-06-06 1997-06-06
US4937597P 1997-06-06 1997-06-06
US4889497P 1997-06-06 1997-06-06
US4937397P 1997-06-06 1997-06-06
US4897297P 1997-06-06 1997-06-06
US4889997P 1997-06-06 1997-06-06
US4889297P 1997-06-06 1997-06-06
US4891697P 1997-06-06 1997-06-06
US4889597P 1997-06-06 1997-06-06
US4894997P 1997-06-06 1997-06-06
US4889797P 1997-06-06 1997-06-06
US4891797P 1997-06-06 1997-06-06
US4896397P 1997-06-06 1997-06-06
US4902097P 1997-06-06 1997-06-06
US4888097P 1997-06-06 1997-06-06
US4888297P 1997-06-06 1997-06-06
US4888597P 1997-06-06 1997-06-06
US4889897P 1997-06-06 1997-06-06
US4888497P 1997-06-06 1997-06-06
US4937497P 1997-06-06 1997-06-06
US4890197P 1997-06-06 1997-06-06
US4888197P 1997-06-06 1997-06-06
US4897197P 1997-06-06 1997-06-06
US4896297P 1997-06-06 1997-06-06
US4901997P 1997-06-06 1997-06-06
US4896497P 1997-06-06 1997-06-06
US4889697P 1997-06-06 1997-06-06
US4897497P 1997-06-06 1997-06-06
US4889397P 1997-06-06 1997-06-06
US4887597P 1997-06-06 1997-06-06
US4891597P 1997-06-06 1997-06-06
US4887897P 1997-06-06 1997-06-06
US60/048,971 1997-06-06
US60/048,878 1997-06-06
US60/048,882 1997-06-06
US60/049,373 1997-06-06
US60/049,374 1997-06-06
US60/048,917 1997-06-06
US60/048,916 1997-06-06
US60/048,895 1997-06-06
US60/048,883 1997-06-06
US60/048,915 1997-06-06
US60/048,898 1997-06-06
US60/048,964 1997-06-06
US60/048,900 1997-06-06
US60/049,020 1997-06-06
US60/048,894 1997-06-06
US60/048,881 1997-06-06
US60/048,949 1997-06-06
US60/048,972 1997-06-06
US60/049,019 1997-06-06
US60/048,897 1997-06-06
US60/048,880 1997-06-06
US60/048,893 1997-06-06
US60/048,962 1997-06-06
US60/048,877 1997-06-06
US60/048,875 1997-06-06
US60/048,876 1997-06-06
US60/048,885 1997-06-06
US60/048,901 1997-06-06
US60/048,963 1997-06-06
US60/048,974 1997-06-06
US60/048,896 1997-06-06
US60/049,375 1997-06-06
US60/048,899 1997-06-06
US60/048,892 1997-06-06
US60/048,884 1997-06-06
US5766797P 1997-09-05 1997-09-05
US5766697P 1997-09-05 1997-09-05
US5763597P 1997-09-05 1997-09-05
US5764797P 1997-09-05 1997-09-05
US5758497P 1997-09-05 1997-09-05
US5777197P 1997-09-05 1997-09-05
US5776097P 1997-09-05 1997-09-05
US5765097P 1997-09-05 1997-09-05
US5766197P 1997-09-05 1997-09-05
US5762997P 1997-09-05 1997-09-05
US5777797P 1997-09-05 1997-09-05
US5764397P 1997-09-05 1997-09-05
US5766897P 1997-09-05 1997-09-05
US5764497P 1997-09-05 1997-09-05
US5766297P 1997-09-05 1997-09-05
US5764597P 1997-09-05 1997-09-05
US5776997P 1997-09-05 1997-09-05
US5777497P 1997-09-05 1997-09-05
US5764997P 1997-09-05 1997-09-05
US5765197P 1997-09-05 1997-09-05
US5777897P 1997-09-05 1997-09-05
US5764697P 1997-09-05 1997-09-05
US5764897P 1997-09-05 1997-09-05
US5777097P 1997-09-05 1997-09-05
US5776597P 1997-09-05 1997-09-05
US5765497P 1997-09-05 1997-09-05
US5776497P 1997-09-05 1997-09-05
US5762897P 1997-09-05 1997-09-05
US5776397P 1997-09-05 1997-09-05
US5762797P 1997-09-05 1997-09-05
US5776197P 1997-09-05 1997-09-05
US5764297P 1997-09-05 1997-09-05
US5777597P 1997-09-05 1997-09-05
US5777697P 1997-09-05 1997-09-05
US5763497P 1997-09-05 1997-09-05
US5776297P 1997-09-05 1997-09-05
US60/057,628 1997-09-05
US60/057,769 1997-09-05
US60/057,771 1997-09-05
US60/057,648 1997-09-05
US60/057,584 1997-09-05
US60/057,644 1997-09-05
US60/057,776 1997-09-05
US60/057,777 1997-09-05
US60/057,662 1997-09-05
US60/057,764 1997-09-05
US60/057,642 1997-09-05
US60/057,634 1997-09-05
US60/057,650 1997-09-05
US60/057,778 1997-09-05
US60/057,654 1997-09-05
US60/057,627 1997-09-05
US60/057,763 1997-09-05
US60/057,774 1997-09-05
US60/057,666 1997-09-05
US60/057,668 1997-09-05
US60/057,629 1997-09-05
US60/057,667 1997-09-05
US60/057,647 1997-09-05
US60/057,649 1997-09-05
US60/057,651 1997-09-05
US60/057,646 1997-09-05
US60/057,645 1997-09-05
US60/057,661 1997-09-05
US60/057,760 1997-09-05
US60/057,770 1997-09-05
US60/057,762 1997-09-05
US60/057,761 1997-09-05
US60/057,775 1997-09-05
US60/057,643 1997-09-05
US60/057,635 1997-09-05
US7092397P 1997-12-18 1997-12-18
US60/057,765 1997-12-19
US60/048,970 1997-12-19
US60/070,923 1997-12-19
PCT/US1998/011422 WO1998054963A2 (fr) 1997-06-06 1998-06-04 207 proteines secretees humaines

Publications (1)

Publication Number Publication Date
CA2291260A1 true CA2291260A1 (fr) 1998-12-10

Family

ID=27587074

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002291260A Abandoned CA2291260A1 (fr) 1997-06-06 1998-06-04 207 proteines secretees par l'etre humain

Country Status (3)

Country Link
EP (1) EP1039801A4 (fr)
CA (1) CA2291260A1 (fr)
WO (1) WO1998054963A2 (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0970209A1 (fr) * 1997-03-28 2000-01-12 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
WO1999007840A1 (fr) * 1997-08-06 1999-02-18 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
US7378507B2 (en) * 1997-09-18 2008-05-27 Genentech, Inc. PRO217 polypeptides
US6075136A (en) * 1998-02-17 2000-06-13 Incyte Pharmaceuticals, Inc. Prostate-associated serine protease
EP0939124A3 (fr) * 1998-02-24 2001-03-21 Smithkline Beecham Plc Séquences de la MBGP1
CA2321970A1 (fr) * 1998-02-26 1999-09-02 Human Genome Sciences, Inc. Proteines secretees par l'homme
JP2002506615A (ja) * 1998-02-27 2002-03-05 財団法人相模中央化学研究所 膜貫通ドメインを有するヒト蛋白質とそれをコードするｄｎａ
AU3010199A (en) * 1998-03-18 1999-10-11 Icos Corporation Human leupaxin polypeptide and dna encoding it, their uses
GB9807722D0 (en) * 1998-04-08 1998-06-10 Smithkline Beecham Plc Novel compounds
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor
EP1108042B1 (fr) 1998-08-07 2008-11-26 Immunex Corporation Molecules designees b7l-1
US6528297B1 (en) * 1998-08-31 2003-03-04 Institute Of Genetics Fudan University Human lysozyme gene, its encoded polypeptide and the method for preparing them
AU2003204361B2 (en) * 1998-09-01 2006-03-30 Genentech, Inc. Further pro polypeptides and sequences thereof
CA2344657A1 (fr) * 1998-09-18 2000-03-30 Incyte Pharmaceuticals, Inc. Proteine de liaison isre humaine
JP2002525117A (ja) * 1998-09-30 2002-08-13 ミレニアム・フアーマシユーチカルズ・インコーポレーテツド Ｓｌｇｐタンパク質及び核酸分子並びにそれらの使用
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6020164A (en) * 1998-10-21 2000-02-01 Incyte Pharmaceuticals, Inc. Human RNA binding proteins
EP1132473A4 (fr) * 1998-11-20 2002-06-12 Fuso Pharmaceutical Ind Nouvelle serine protease bssp6
HK1041025A1 (zh) * 1998-12-23 2002-06-28 Corixa Corporation 用於結腸癌的免疫治療和診斷的化合物及其使用方法
GB9828704D0 (en) 1998-12-24 1999-02-17 Nippon Glaxo Limited Proteins
US6586572B2 (en) 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6958361B2 (en) 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6387697B1 (en) 1998-12-28 2002-05-14 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
CA2361293A1 (fr) * 1999-02-10 2000-08-17 Human Genome Sciences, Inc. 33 proteines humaines secretees
WO2000077023A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 48 proteines secretees humaines
CA2361277A1 (fr) * 1999-03-12 2000-09-21 Craig A. Rosen Proteines humaines secretees (49)
CA2368068A1 (fr) * 1999-03-18 2000-09-21 Steven M. Ruben 27 proteines humaines secretees
EP1165590A4 (fr) * 1999-03-23 2003-02-26 Human Genome Sciences Inc 49 proteines humaines secretees
JP2003501008A (ja) * 1999-03-26 2003-01-14 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
EP1177287A2 (fr) * 1999-04-09 2002-02-06 Chiron Corporation Proteines humaines secretees
EP1174504A4 (fr) * 1999-04-09 2003-01-08 Shionogi & Co Gene associe a l'apoptose
CA2371172A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 50 proteines humaines secretees
AU4237700A (en) * 1999-04-15 2000-11-02 Osiris Therapeutics, Inc. Genes and expression products from hematopoietic cells
AU775409B2 (en) * 1999-04-30 2004-07-29 Kurokawa, Kiyoshi Meg-3 protein
ATE323153T1 (de) * 1999-05-13 2006-04-15 Johnson & Johnson Pharm Res Sphingosinekinase
CA2374341A1 (fr) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Nouveau polypeptide
AU5458300A (en) * 1999-06-07 2000-12-28 Human Genome Sciences, Inc. 26 human secreted proteins
AU5177000A (en) * 1999-06-11 2001-01-02 Human Genome Sciences, Inc. 50 human secreted proteins
CA2383041A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 proteines secretees humaines
AU5308200A (en) * 1999-06-11 2001-01-02 Human Genome Sciences, Inc. 48 human secreted proteins
WO2001005969A2 (fr) * 1999-07-14 2001-01-25 Incyte Genomics, Inc. Proteines de transfert d'electrons
AU6181300A (en) * 1999-07-29 2001-02-19 Helix Research Institute Liver cancer-associated genes
WO2001021794A2 (fr) * 1999-09-20 2001-03-29 Ludwig Institute For Cancer Research Polypeptides associant smad
US6673570B1 (en) * 1999-09-20 2004-01-06 Ludwig Institute For Cancer Research Smad associating polypeptides
JP2003517297A (ja) * 1999-09-23 2003-05-27 ライジェル・ファーマシューティカルズ・インコーポレイテッド チェックポイント遺伝子関連細胞周期タンパク質、組成物および使用法
WO2001031029A2 (fr) * 1999-10-28 2001-05-03 Warner-Lambert Company Gene de la sphingosine kinase humaine
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
DE60137829D1 (de) * 2000-01-13 2009-04-16 Genentech Inc Menschliche stra6 polypeptide
CA2402148A1 (fr) * 2000-02-14 2001-08-23 Curagen Corporation Nouvelles kinases de sphingosine
AU2001245308A1 (en) * 2000-02-24 2001-09-03 Human Genome Sciences, Inc. 207 human secreted proteins
US20020098163A1 (en) * 2000-07-24 2002-07-25 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR21 and TR22
EP1339841A2 (fr) * 2000-09-27 2003-09-03 Vlaams Interuniversitair Instituut voor Biotechnologie Identification de genes suppresseurs du neuroblastome
US6630325B1 (en) * 2000-10-19 2003-10-07 Maine Medical Center Research Institute Compositions, methods and kits relating to remodel
EP1397383A2 (fr) * 2001-06-20 2004-03-17 Genentech, Inc. Nouveau polypeptide secrete et methodes de traitement des troubles osseux
WO2003025135A2 (fr) * 2001-09-14 2003-03-27 Gene Logic, Inc. Genes associes a des tumeurs malignes
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0871702T3 (da) * 1994-12-06 2005-09-19 Immunex Corp Cytokin betegnet Lerk-7
AU727480B2 (en) * 1995-07-19 2000-12-14 Genetics Institute, Llc Human CTLA-8 and uses of CTLA-8-related proteins

Also Published As

Publication number Publication date
EP1039801A1 (fr) 2000-10-04
WO1998054963A2 (fr) 1998-12-10
EP1039801A4 (fr) 2003-03-26

Similar Documents

Publication Publication Date Title
US20030055236A1 (en) Secreted protein HKABT24
US20050089911A1 (en) 87 human secreted proteins
US20090088555A1 (en) 44 Human Secreted Proteins
EP1100869A1 (fr) 98 proteines humaines secretees
CA2295474A1 (fr) 123 proteines humaines secretees
CA2331154A1 (fr) Polypeptides presentant une sequence distincte comprenant une sous-unite de facteur de croissance insulinomimetique labile en milieu acide
US6525174B1 (en) Precerebellin-like protein
CA2332109A1 (fr) 97 proteines humaines secretees
EP1039801A1 (fr) 207 proteines humaines secretees
CA2323761A1 (fr) 95 proteines humaines secretees
CA2319129A1 (fr) 67 proteines humaines secretees
WO1998054206A1 (fr) 32 proteines secretees par l'homme
CA2294526A1 (fr) 86 proteines secretees humaines
US6878687B1 (en) Protein HMAAD57
WO1999024836A1 (fr) 125 proteines secretees humaines
CA2296815A1 (fr) Serie de 64 proteines humaines secretees
CA2322728A1 (fr) 31 proteines humaines secretees
CA2294705A1 (fr) 19 proteines secretees par l'etre humain
CA2305690A1 (fr) 53 proteines secretees humaines
EP1042674A1 (fr) 148 proteines humaines secretees
CA2298852A1 (fr) 83 proteines humaines secretees
CA2302387A1 (fr) 29 proteines humaines secretees
WO1999018208A1 (fr) 101 proteines humaines secretees
US20050214844A1 (en) 86 human secreted proteins
US20070238664A1 (en) 70 Human Secreted Proteins

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead